Extension Study to Evaluate the Safety of Q8003 in Patients With Acute Moderate to Severe Pain - Contacts and Locations

Extension Study to Evaluate the Safety of Q8003 in Patients With Acute Moderate to Severe Pain

This study has been completed.

Study NCT00565760. Last updated on June 9, 2008. Information provided by QRxPharma Inc.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00565760

Locations


United States, California
	Advanced Clinical Research Institute
	Anaheim, California, United States, 92801

United States, Maryland
	Chesapeake Research Group
	Pasadena, Maryland, United States, 21122

United States, Pennsylvania
	Advanced Regional Center for Foot and Ankle Care
	Altoona, Pennsylvania, United States, 16602

United States, Texas
	Scirex Research Center
	Houston, Texas, United States, 77081

United States, Utah
	Lifetree Clinical Research
	Salt Lake City, Utah, United States, 84106
	Jean Brown Research
	Salt Lake City, Utah, United States, 84124

Sponsors and Collaborators

QRxPharma Inc.

Investigators


Study Director:	Warren Stern, Ph.D.	QRxPharma Inc.